Skip to main content
Treating multi drug resistant TB and HIV/AIDS in Manipur, India

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.

During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.

In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, promoting health exceptions to global trade agreements.

In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.

 
Website

MSF Access Campaign

msfaccess.org
 
Drugs, medical material, shelters and NFI sent to Syria
Syria

Despite cease fire catalogue of horror continues in besieged areas

Project Update 7 Apr 2016
 
South Sudan - Pibor violence and looting
South Sudan

MSF issues open letter on nationwide lack of essential medicines

Statement 7 Apr 2016
 
MSF TB Treatment in Mumbai, India
India

At EU-India Summit, India must defend its pharmacy of the developing world

Press Release 29 Mar 2016
 
MSF treats DR-TB cases
Tuberculosis

Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

Report 21 Mar 2016
 
PCV Vaccination Campaign in Yida Camp
Access to medicines

MSF launches challenge to Pfizer’s patent on the pneumonia vaccine in India to increase access to more affordable versions

Crisis Update 11 Mar 2016
 
Jeanine and her daughters.
Democratic Republic of Congo

Suffering has been a part of my life. But I fight. I'm still standing!

Voices from the Field 10 Mar 2016
 
MSF Clinic Hepatitis C Unit - Noor Alam #3
Pakistan

Stories from patients cured of hepatitis C at MSF’s Machar Clinic in Karachi

Voices from the Field 9 Mar 2016
 
MSF Clinic Hepatitis C Unit
Pakistan

When they are diagnosed with hepatitis C, patients think they will die

Voices from the Field 9 Mar 2016
 
Hepatitis C in Mumbai
India

Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India

Project Update 26 Feb 2016
Up Next
30 August 2019